Reporting owner · Q3 2026 · CIK 2004380

Lippis Daniel J.: insider trades.

Lippis Daniel J. reported 7 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($168K), across 1 company.

Transactions
7
Purchases (P)
0
Sales (S)
3
Companies
1
Name as filed
Lippis Daniel J.

Companies

CompanyRelationshipTransactions
Edwards Lifesciences Corp (EW)Officer · CVP, TAVR7

Transactions

7 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-11Edwards Lifesciences CorpM619$72.6840,653Form 4
2026-09-11Edwards Lifesciences CorpS619$87.5140,034Form 4
2026-08-11Edwards Lifesciences CorpM619$72.6840,653Form 4
2026-08-11Edwards Lifesciences CorpS619$92.0340,034Form 4
2026-07-10Edwards Lifesciences CorpS619$91.740,034Form 4
2026-07-10Edwards Lifesciences CorpM619$72.6840,653Form 4
2026-07-07Edwards Lifesciences CorpF377$95.1840,034Form 4

Questions

What stock did Lippis Daniel J. buy or sell?

Lippis Daniel J. reported 7 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($168K), across 1 company.

Is Lippis Daniel J. the same person as other filers with this name?

This page covers SEC CIK 2004380 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/lippis-daniel-j-2004380.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.